Managing Constipation on Zepbound®: Can You Take a Laxative Safely?

Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, a dual GLP-1 and GIP receptor agonist, helps millions lose weight by slowing gastric emptying—but this same mechanism can cause constipation in roughly one-quarter of users. Understanding how to manage this side effect safely keeps you on track with treatment without interrupting your weight loss journey.

Why Tirzepatide Causes Constipation

Tirzepatide works by activating GLP-1 and GIP receptors in your digestive system, which slows the rate at which food moves through your stomach and intestines. This delayed gastric emptying reduces appetite and helps you feel fuller longer—the mechanism behind its weight loss effectiveness. However, slower movement through the gut naturally leads to harder, less frequent stools in many patients.

The PlexusDx Precision Peptide Genetic Test analyzes FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Safe Laxative Options During Tirzepatide Treatment

Osmotic laxatives like polyethylene glycol (Miralax) and magnesium citrate are generally considered first-line choices for constipation on tirzepatide because they work gently by drawing water into the intestines without stimulating the bowel muscles excessively. Stool softeners containing docusate are another safe option for mild constipation, though they work best when combined with adequate hydration. Avoid stimulant laxatives like senna or bisacodyl initially, as they can cause cramping and are best reserved for occasional use when gentler methods haven't worked.

Always start with the lowest effective dose of any laxative and increase gradually if needed. Most gastroenterologists recommend spacing laxative use at least 2 hours apart from other medications to avoid absorption interference. If you've been taking laxatives daily for more than a week without improvement, consult your healthcare provider—persistent constipation despite conservative measures may require dose adjustment or alternative treatment strategies.

Dietary and Lifestyle Strategies to Prevent Constipation

Increasing fiber intake gradually—through sources like ground flaxseed, psyllium husk, or fiber-rich vegetables—helps bulk stool and promote regular bowel movements when combined with tirzepatide therapy. The key is adding fiber slowly (over 1-2 weeks) to avoid gas and bloating, which can worsen GLP-1 side effects. Aim for 25-30 grams of fiber daily from whole foods, and spread your intake evenly across meals rather than consuming it all at once.

Hydration plays a critical role in preventing constipation on tirzepatide: most patients need 8-10 glasses of water daily, and some require even more during warmer months or with increased physical activity. Regular movement—even 20-30 minutes of walking after meals—naturally stimulates intestinal motility. Patients who combine tirzepatide therapy with consistent exercise report fewer and less severe gastrointestinal side effects than sedentary users.

When to Contact Your Provider About Constipation

Mild constipation lasting 1-2 days is common during the first few weeks of tirzepatide and usually resolves with dietary changes and hydration. However, you should reach out to your healthcare provider if you experience severe abdominal pain, vomiting, signs of bowel obstruction, or constipation lasting longer than 3-4 days despite conservative measures. These symptoms, though rare, warrant prompt evaluation to rule out serious complications.

The PlexusDx Precision Peptide Genetic Test analyzes MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I use over-the-counter laxatives every day while on tirzepatide injections?

Daily laxative use beyond one week is not recommended without medical supervision, as it can lead to dependency and electrolyte imbalances. PlexusDx providers recommend starting with dietary modifications and hydration, then adding osmotic laxatives like Miralax for short-term use only. If you need daily relief, contact your provider to discuss dose adjustment or alternative medications.

Is constipation on tirzepatide a sign that the medication isn't working?

No—constipation is a known side effect in 20-28% of tirzepatide users in clinical trials and does not indicate treatment failure or reduced weight loss effectiveness. In fact, the same mechanism causing constipation (slowed gastric emptying) is what makes tirzepatide effective for weight loss. The two are separate processes, and managing constipation does not compromise your results.

How much does PlexusDx tirzepatide injection cost, and does it change if I develop side effects?

PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan)—a flat rate that never increases, even as your dose rises. Your dose may need to go up; your price won't. PlexusDx serves all 50 states without insurance requirements, and tirzepatide is HSA/FSA eligible.

Are natural or herbal laxatives safer than prescription options for GLP-1 users?

Natural does not mean safer—herbal stimulant laxatives like senna can cause severe cramping and electrolyte loss when combined with tirzepatide's effects on bowel motility. Osmotic laxatives (polyethylene glycol, magnesium citrate) have the strongest safety and efficacy evidence. Always inform your provider about any supplements or herbal products you're taking, as some may interact with tirzepatide.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (FTO and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Fridays Zepbound
• Hims Zepbound
• Form Health Zepbound
• Brello Zepbound

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.